The Einthoven Laboratory for Vascular and Regenerative Medicine, Division of Nephrology, Department of Internal Medicine, and.
Section Electron Microscopy, Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands.
J Am Soc Nephrol. 2019 Oct;30(10):1886-1897. doi: 10.1681/ASN.2019020192. Epub 2019 Jul 15.
A glycocalyx envelope consisting of proteoglycans and adhering proteins covers endothelial cells, both the luminal and abluminal surface. We previously demonstrated that short-term loss of integrity of the luminal glycocalyx layer resulted in perturbed glomerular filtration barrier function.
To explore the role of the glycocalyx layer of the endothelial extracellular matrix in renal function, we generated mice with an endothelium-specific and inducible deletion of hyaluronan synthase 2 (Has2), the enzyme that produces hyaluronan, the main structural component of the endothelial glycocalyx layer. We also investigated the presence of endothelial hyaluronan in human kidney tissue from patients with varying degrees of diabetic nephropathy.
Endothelial deletion of Has2 in adult mice led to substantial loss of the glycocalyx structure, and analysis of their kidneys and kidney function showed vascular destabilization, characterized by mesangiolysis, capillary ballooning, and albuminuria. This process develops over time into glomerular capillary rarefaction and glomerulosclerosis, recapitulating the phenotype of progressive human diabetic nephropathy. Using a hyaluronan-specific probe, we found loss of glomerular endothelial hyaluronan in association with lesion formation in tissue from patients with diabetic nephropathy. We also demonstrated that loss of hyaluronan, which harbors a specific binding site for angiopoietin and a key regulator of endothelial quiescence and maintenance of EC barrier function results in disturbed angiopoietin 1 Tie2.
Endothelial loss of hyaluronan results in disturbed glomerular endothelial stabilization. Glomerular endothelial hyaluronan is a previously unrecognized key component of the extracelluar matrix that is required for glomerular structure and function and lost in diabetic nephropathy.
由蛋白聚糖和黏附蛋白组成的糖萼包膜覆盖着内皮细胞,包括腔侧和基底外侧表面。我们之前的研究表明,腔侧糖萼层的短期完整性丧失会导致肾小球滤过屏障功能紊乱。
为了探索内皮细胞细胞外基质糖萼层在肾功能中的作用,我们生成了一种内皮细胞特异性和诱导型透明质酸合酶 2(Has2)缺失的小鼠,Has2 是产生透明质酸的酶,透明质酸是内皮糖萼层的主要结构成分。我们还研究了不同程度糖尿病肾病患者的人肾组织中内皮透明质酸的存在情况。
成年小鼠内皮细胞 Has2 的缺失导致糖萼结构的大量丢失,对其肾脏和肾功能的分析表明血管不稳定,表现为系膜溶解、毛细血管气球样变和白蛋白尿。这个过程随着时间的推移发展为肾小球毛细血管稀疏和肾小球硬化,重现了进行性人类糖尿病肾病的表型。使用透明质酸特异性探针,我们发现与糖尿病肾病患者组织的病变形成相关的肾小球内皮透明质酸丢失。我们还证明,透明质酸的丢失会导致血管生成素 1 Tie2 的紊乱,而透明质酸携带有血管生成素的特异性结合位点,是内皮静止和维持 EC 屏障功能的关键调节因子。
内皮细胞透明质酸的丢失会导致肾小球内皮稳定性的紊乱。肾小球内皮透明质酸是细胞外基质中以前未被认识的一个关键组成部分,对于肾小球的结构和功能是必需的,并且在糖尿病肾病中丢失。